Leuprorelin Acetate SR 11.25 mg for Injection Specified Drug-use Survey "Long-term Use Survey on Premenopausal Breast Cancer Patients (96 Weeks)"
NCT02154139
·
clinicaltrials.gov ↗
COMPLETED
Status
651
Enrollment
INDUSTRY
Sponsor class
Conditions
Breast Cancer
Interventions
DRUG:
Leuprorelin acetate
Sponsor
Takeda